JV - Award for Best Belgian Sustainability Report

ITM publications in 2011Department of MicrobiologyPublications in international peer-reviewedjournals with impact factorAbadia E, Zhang J, Ritacco V, Kremer K, Ruimy R, Rigouts L, Gomes HM,Ribeiro Elias A, Fauville-Dufaux M, Stoffels K, Rasolofo-RazanamparanyV, Garcia de Viedma D, Herranz M, Al-Hajoj S, Rastogi N, Garzelli C,Tortoli E, Suffys PN, van Soolingen D, Refrégier G, Sola C. The use ofmicrobead-based spoligotyping for Mycobacterium tuberculosiscomplex to evaluate the quality of the conventional method : Providingguidelines for quality assurance when working on membranes. BMCInfect Dis 2011;11(110):1-8.Abebe G, Paasch F, Apers L, Rigouts L, Colebunders R. Tuberculosisdrug resistance testing by molecular methods: opportunitiesand challenges in resource limited settings. J Microbiol Methods2011;84(2):155-60.Allotey PA, Diniz S, Dejong J, Delvaux T, Gruskin S, Fonn S. Sexual andreproductive health and rights in public health education. ReprodHealth Matters 2011;19(38):56-68.Almeida da Silva PE, Von Groll A, Martin A, Palomino JC. Efflux asmechanism for drug resistance in Mycobacterium tuberculosis. FEMSImmunol Med Microbiol 2011;63(1):1-9.Almeida da Silva PE, Palomino JC. Molecular basis and mechanisms ofdrug resistance in Mycobacterium tuberculosis: classical and new drugs.J Antimicrob Chemother 2011;66(7):1417-30.Ariën KK, Gali Y, Vanham G. The “gatekeeper” hypothesis challenged ina human cervico-vaginal tissue model for HIV-1 transmission [letter].Mucosal Immunol 2011;4(1):121-2.Ariën KK, Jespers V, Vanham G. HIV sexual transmission andmicrobicides. Rev Med Virol 2011;21(2):110-33.Assefa Y, Kiflie A, Tesfaye D, Haile Mariam D, Kloos H, Wouters E, LagaM, Van Damme W. Outcomes of antiretroviral treatment program inEthiopia: retention of patients in care is a major challenge and variesacross health facilities. BMC Health Serv Res 2011;11(81):1-7.Aung KJM, Nandi P, Hamid Salim A, Hossain A, Van Deun A. Hydrochloricvs. sulphuric acid in water for Ziehl-Neelsen staining of acid-fast bacilli.Int J Tuberc Lung Dis 2011;15(7):955-8.Balla-Jhagjhoorsingh SS, Willems B, Heyndrickx L, Heyndrickx L,Vereecken K, Janssens W, Seaman MS, Corti D, Lanzavecchia A, DavisD, Vanham G. Characterization of neutralizing profiles in HIV-1 infectedpatients from whom the HJ16, HGN194 and HK20 mAbs were obtained.PLoS ONE 2011;6(10):e25488.Berg S, Garcia-Pelayo MC, Müller B, Hailu E, Asiimwe B, Kremer K, DaleJ, Boniotti B, Rodriguez S, Hilty M, Rigouts L, Firdessa R, MachadoA, Mucavele C, Ngandolo BNR, Bruchfeld J, Boschiroli L, Müller A,Sahraoui N, Pacciarini M, Cadmus S, Joloba M, van Soolingen D, MichelAL, Djonne B, Aranaz A, Zinsstag J, van Helden P, Portaels F, Kazwala R,Kallenius G, Hewinson RG, Aseffa A, Gordon SV, Smith NH. African 2; aclonal complex of Mycobacterium bovis epidemiologically important inEast Africa. J Bacteriol 2011;193(3):670-8.Best I, López G, Talledo M, MacNamara A, Verdonck K, González E,Tipismana M, Asquith B, Gotuzzo E, Vanham G, Clark D. An interferongammaELISPOT assay with two cytotoxic T cell epitopes derivedfrom HTLV-1 Tax region 161-233 discriminates HTLV-1-associatedmyelopathy/tropical spastic paraparesis patients from asymptomaticHTLV-1 carriers in a Peruvian population. AIDS Res Hum Retrovir2011;27(11):1207-12.Boukary AR, Thys E, Mamadou S, Rigouts L, Matthys F, Vias Franck SG,Gamatie D, Yenikoye A, Saegerman C. La tuberculose à Mycobacteriumbovis en Afrique subsaharienne. Ann Méd Vét 2011; 155(1): 23-37.Conesa-Botella A, Massinga-Loembe M, Manabe YC, Worodria W,Mazakpwe D, Luzinda K, Mayanja-Kizza H, Miri M, Mbabazi O, KooleO, Kestens L, Colebunders R. Urinary lipoarabinomannan as predictorfor the tuberculosis immune reconstitution inflammatory syndrome. JAcquir Immune Defic Syndr 2011;58(5):463-8.Crucitti T, Jespers V, Mulenga C, Khondowe S, Vandepitte J, Buvé A.Non-sexual transmission of Trichomonas vaginalis in adolescent girlsattending school in Ndola, Zambia. PLoS ONE 2011;6(1):e16310.Crucitti T, Taylor D, Beelaert G, Fransen K, Van Damme L. Performanceof a rapid and simple HIV testing algorithm in a multicenter phase IIImicrobicide clinical trial. Clin Vaccine Immunol 2011;18(9):1480-5.De Ryck I, Van den Berghe W, Antonneau C, Colebunders R. Awarenessof hepatitis C infection among men who have sex with men in Flanders,Belgium. Acta Clin Belg 2011;66(1):46-8.Delvaux T, Samreth S, Barr-DiChiara M, Seguy N, Guerra K, Ngauv B,Ouk V, Laga M, Mean C. Linked response for prevention, care andtreatment of HIV/AIDS, STIs and reproductive health issues: resultsafter 18 months of implementation in five operational districts inCambodia. J Acquir Immune Defic Syndr 2011;57(3):e47-e55.Diaw PA, Daneau G, Coly AA, Ndiaye BP, Wade D, Camara M, Mboup S,Kestens L, Dieye TN. Multisite evaluation of a point-of-care instrumentfor CD4(+) T-cell enumeration using venous and finger-prick blood:the PIMA CD4. J Acquir Immune Defic Syndr 2011;58(4):e103-e111.Dieye TN, Diaw PA, Daneau G, Wade D, Niang SM, Camara M, DialloAA, Toure Kane C, Ndiaye HD, Mbengue B, Dieye A, Kestens L, MboupS. Evaluation of a flow cytometry method for CD4 T cell enumerationbased on volumetric primary CD4 gating using thermoresistantreagents. J Immunol Methods 2011;372(1-2):7-13.Fraga AG, Cruz A, Martins TG, Torrado E, Saraiva M, Pereira DR, MeyersWM, Portaels F, Silva MT, Castro AG, Pedrosa J. Mycobacterium ulceranstriggers T cell immunity followed by local and regional but not systemicimmunosuppression. Infect Immun 2011;79(1):421-30.Haldar B, Burda S, Williams C, Heyndrickx L, Vanham G, Gorny MK,Nyambi P. Longitudinal study of primary HIV-1 isolates in drug-naiveindividuals reveals the emergence of variants sensitive to anti-HIV-1monoclonal antibodies. PLoS ONE 2011;6(2):e17253.Hijazi K, Wang Y, Scala C, Jeffs S, Longstaff C, Stieh D, Haggarty B,Vanham G, Schols D, Balzarini J, Jones IM, Hoxie J, Shattock R, KellyCG. DC-SIGN increases the affinity of HIV-1 envelope glycoproteininteraction with CD4. PLoS ONE 2011;6(12):e28307.Horemans T, Deschacht M, Clais S, Van Camp J, De Rijk P, Holvoet J,Van Assche T, Maes L, Cos P. An alternative, sensitive method to detectHelicobacter pylori DNA in feces. Helicobacter 2011;16(2):113-8.Jennes W, Verheyden S, Demanet C, Menten J, Vuylsteke B, NkengasongJN, Kestens L. Low CD4+ T cell counts among African HIV-1 infectedsubjects with group B KIR haplotypes in the absence of specificinhibitory KIR ligands. PLoS ONE 2011;6(2):e17043.Jespers V, Francis SC, van de Wijgert J, Crucitti T. Methodological issuesin sampling the local immune system of the female genital tract in theONDERZOEK | 61